Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period

Cancer

Volumn 120, Issue 10, 2014, Pages 1532-1539

  Aizer, Ayal A ^a   Wilhite, Tyler J ^a   Chen, Ming Hui ^b   Graham, Powell L ^a   Choueiri, Toni K ^a   Hoffman, Karen E ^c   Martin, Neil E ^a   Trinh, Quoc Dien ^a   Hu, Jim C ^d   Nguyen, Paul L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

African American; Asian American; black; cancer; Hispanic; metastatic; mortality; radiation; surgery; white

Indexed keywords

ADULT; ADVANCED CANCER; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUCASIAN; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEALTH DISPARITY; HISPANIC; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; TREND STUDY;

AFRICAN AMERICAN; ASIAN AMERICAN; BLACK; CANCER; HISPANIC; METASTATIC; MORTALITY; RADIATION; SURGERY; WHITE;

ADULT; AFRICAN AMERICANS; AGED; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; INCOME; MALE; MARITAL STATUS; MIDDLE AGED; NEOPLASMS; ODDS RATIO; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84899917038     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28617     Document Type: Article

References (31)

1. United States Census Bureau. https://www.census.gov/prod/cen2010/briefs/ c2010br-05.pdf. Accessed January 20, 2013.
2. Ooi SL, Martinez ME, Li CI,. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011; 127: 729-738.
3. Fine JP, Gray RJ,. A proportional hazards model for the sub-distribution of a competing risk. J Am Stat Assoc. 1999; 94: 496-509.
4. American Cancer Society. Cancer Facts & Figures 2012. www.cancer.gov. Accessed November 1, 2012.
5. American Cancer Society. Cancer Treatment and Survivorship Facts and Figures 2012-2013. cancer.org/acs/groups/content/@epidemiologysurveilance/ documents/document/acspc-033876.pdf. Accessed October 15, 2013.
6. Surveillance, Epidemiology, and End Results (SEER) Program. Research Data (1973-2009). Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2012.
7. Greene FL, Page DL, Fleming ID, et al, eds. American Joint Committee on Cancer Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002.
8. Gray RJ,. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988; 16: 1140-1154.
9. United States Department of Agriculture. Rural-Urban Continuum Codes. http://ers.usda.gov/datafiles/RuralUrban-Continuum-Codes/ruralurbancodes2003. xls. Accessed January 13, 2013.
10. United States Census Bureau. Census 2000 Gateway. census.gov/main/www/ cen2000.html. Accessed December 12, 2012.
11. Gross CP, Smith BD, Wolf E, Andersen M,. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008; 112: 900-908.
12. Rosen P, Pfister D, Young D, et al. Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancer. Urology. 2012; 80: 749-753.
13. Magi-Galluzzi C, Tsusuki T, Elson P, et al. TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of Caucasian, African-American and Japanese patients. Prostate. 2011; 71: 489-497.
14. Lin NU, Vanderplas A, Hughes ME, et al. Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network. Cancer. 2012; 118: 5463-5472.
15. US Food and Drug Administration. Trastuzumab Product Approval Information. http://fda.gov/Drugs/DevelopmentApprovalProcess/How DrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBio logicApplications/ucm080591.htm.Accessed January 22, 2013.
16. Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M,. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Womens Health (Larchmt). 2011; 20: 1543-1550.
17. Mukhtar RA, Moore AP, Nseyo O, et al. Elevated PCNA+ tumor-associated macrophages in breast cancer are associated with early recurrence and non-Caucasian ethnicity. Breast Cancer Res Treat. 2011; 130: 635-644.
18. Soo RA, Loh M, Mok TS, et al. Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials. J Thorac Oncol. 2011; 6: 1030-1038.
19. Ahn MJ, Lee J, Park YH, et al. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era. J Thorac Oncol. 2010; 5: 1185-1196.
20. Freedman RA, Hughes ME, Ottesen RA, et al. Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network. Cancer. 2013; 119: 839-846.
21. Pitman M, Korets R, Kates M, Hruby GW, McKiernan JM,. Socioeconomic and clinical factors influence the interval between positive prostate biopsy and radical prostatectomy. Urology. 2012; 80: 1027-1032.
22. Salz T, Woo H, Starr TD, Jandorf LH, DuHamel KN,. Ethnic disparities in colonoscopy use among colorectal cancer survivors: a systematic review. J Cancer Surviv. 2012; 6: 372-378.
23. Weekes CV,. African Americans and health literacy: a systematic review. ABNF J. 2012; 23: 76-80.
24. Rust C, Davis C,. Health literacy and medication adherence in underserved African-American breast cancer survivors: a qualitative study. Soc Work Health Care. 2011; 50: 739-761.
25. Friedman DB, Corwin SJ, Dominick GM, Rose ID,. African American men's understanding and perceptions about prostate cancer: why multiple dimensions of health literacy are important in cancer communication. J Community Health. 2009; 34: 449-460.
26. Fyffe DC, Hudson SV, Fagan JK, Brown DR,. Knowledge and barriers related to prostate and colorectal cancer prevention in underserved black men. J Natl Med Assoc. 2008; 100: 1161-1167.
27. Murthy VH, Krumholz HM, Gross CP,. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004; 291: 2720-2726.
28. Gorelick PB, Harris Y, Burnett B, Bonecutter FJ,. The recruitment triangle: reasons why African Americans enroll, refuse to enroll, or voluntarily withdraw from a clinical trial. An interim report from the African-American Antiplatelet Stroke Prevention Study (AAASPS). J Natl Med Assoc. 1998; 90: 141-145.
29. Obeidat NA, Pradel FG, Zuckerman IH, et al. Racial/ethnic and age disparities in chemotherapy selection for colorectal cancer. Am J Manag Care. 2010; 16: 515-522.
30. Mack CD, Carpenter W, Meyer AM, Sanoff H, Sturmer T,. Racial disparities in receipt and comparative effectiveness of oxaliplatin for stage III colon cancer in older adults. Cancer. 2012; 118: 2925-2934.
31. Morris AM, Billingsley KG, Hayanga AJ, Matthews B, Baldwin LM, Birkmeyer JD,. Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst. 2008; 100: 738-744.